Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Vera Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get VERA alerts

About Marshall Fordyce

Marshall Fordyce is recorded as Board Member at Vera Therapeutics, Inc. (VERA) since January 1, 2016 and CEO at Vera Therapeutics, Inc. (VERA). The newest filing on record that lists Marshall Fordyce as CEO and Board Member at Vera Therapeutics, Inc. (VERA) is dated April 9, 2026. The proxy statement of Vera Therapeutics, Inc. reports total compensation of $6,986,410 for Marshall Fordyce in fiscal 2025, including a base salary of $660,000. Disclosed compensation is on record for 6 fiscal years. Marshall Fordyce has spoken on 2 investor events across 1 company, most recently for Vera Therapeutics, Inc. on October 22, 2026. Vera Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vera Therapeutics, Inc. includes Michael M. Morrissey, Ph.D. (Chairman and Board Member), Sean Grant (CFO), Sean P. Grant (CFO) and 7 others.

Marshall Fordyce on recent calls

“And on behalf of the entire Vera team and all of our partners, I'm thrilled to share with you the final efficacy results of the origin phase three trial of a tachycept for the treatment of adults with IgA nephropathy.”
CEO, Virtual Investor Event: ASN Kidney Week 2026 ·
“Matthew, thanks for having us and me at your conference. Great to have an interview with you today. I'm Marshall Fordyce. I'm the founder and CEO of Vera Therapeutics.”
CEO, Morgan Stanley 24th Annual Global Healthcare Conference ·

Affiliation history

Company network

Leadership on record at Vera Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Vera Therapeutics, Inc. (VERA) $660,000 $6,986,410
2024 Vera Therapeutics, Inc. (VERA) $616,250 $5,648,201
2023 Vera Therapeutics, Inc. (VERA) $585,638 $3,429,733
2022 Vera Therapeutics, Inc. (VERA) $551,340 $4,106,629
2021 Vera Therapeutics, Inc. (VERA) $479,099 $1,485,701
2020 Vera Therapeutics, Inc. (VERA) $360,000 $3,226,305

Recent activity